Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Aug 7, 2014Fourth quarter revenue of $1.12 billion, up 24 percent; Fiscal 2014 revenue of $3.84 billion, up 8 percent.
SAN DIEGO, Aug. 7, 2014/PRNewswire/ – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported results for the quarter and fiscal year ended June 30, 2014,...
-
Aug 6, 2014The only pen needle with patented dual needle shields for enhanced convenience and safety is latest BD innovation for insulin injection
FRANKLIN LAKES, N.J., August 6, 2014 – BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the retail pharmacy...
-
Aug 4, 2014Total Nucleic Acid Reagents Now Available Worldwide - Streamlined Workflow for In-House Developed Assays
BD Diagnostics, a segment of leading global medical technology company BD (Becton, Dickinson, and Company) (NYSE: BDX), announced today the availability of the Total Nucleic Acid (TNA) suite of...
-
Jul 31, 2014ChloraPrep 1 mL Applicator Provides Additional Option to Proven Portfolio of Patient Skin Preparation Products
SAN DIEGO, July 31, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, today announced the launch of its ChloraPrep® 1 mL applicator, the newest addition to...
-
Jul 31, 2014- Announces revenues of $2.157 billion, an increase of 5.1 percent, or 4.6 percent on a foreign currency-neutral basis.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.157 billion for the third fiscal quarter ended June 30, 2014,...
-
Jul 28, 2014Assays bring an innovative solution to microbiology and molecular labs
BD Diagnostics, a segment of BD (Becton, Dickinson and Company), (NYSE: BDX) announced today it has received 510(k) clearance from the U.S. Food and Drug Administration for the BD ProbeTec(TM)...
-
Jul 22, 2014
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 54.5 cents per common share payable on September 30, 2014 to holders of record on...
-
Jul 10, 2014
SAN DIEGO, CA July 10, 2014 /PRNewswire/ – CareFusion Corporation (NYSE: CFN) today announced plans to release fourth quarter and fiscal 2014 results on Thursday, Aug. 7, following the close of...
-
Jun 30, 2014
BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its third fiscal quarter 2014 earnings conference call on Thursday, July 31, at 8:00 a.m....
-
Jun 30, 2014Company Commits to Support Every Newborn Action Plan as Part of 2014 Partners' Forum
As a global medical technology company dedicated to its purpose of "Helping all people live healthy lives," BD (Becton, Dickinson and Company) (NYSE: BDX), is proud to announce its support for and...